Abstract:Non-coding variation in complex human disease has been well established by genome-wide association studies, and is thought to involve regulatory elements, such as enhancers, whose variation affects the expression of the gene responsible for the disease. The regulatory elements often lie far from the gene they regulate, or within introns of genes differing from the regulated gene, making it difficult to identify the gene whose function is affected by a given enhancer variation. Enhancers are connected to their target gene promoters via long-range physical interactions (loops). In our study, we re-mapped, onto the human genome, more than 10,000 enhancers connected to promoters via long-range interactions, that we had previously identified in mouse brain-derived neural stem cells by RNApolII-ChIA-PET analysis, coupled to ChIP-seq mapping of DNA/chromatin regions carrying epigenetic enhancer marks. These interactions are thought to be functionally relevant. We discovered, in the human genome, thousands of DNA regions syntenic with the interacting mouse DNA regions (enhancers and connected promoters). We further annotated these human regions regarding their overlap with sequence variants (single nucleotide polymorphisms, SNPs; copy number variants, CNVs), that were previously associated with neurodevelopmental disease in humans. We document various cases in which the genetic variant, associated in humans to neurodevelopmental disease, affects an enhancer involved in long-range interactions: SNPs, previously identified by genome-wide association studies to be associated with schizophrenia, bipolar disorder, and intelligence, are located within our human syntenic enhancers, and alter transcription factor recognition sites. Similarly, CNVs associated to autism spectrum disease and other neurodevelopmental disorders overlap with our human syntenic enhancers. Some of these enhancers are connected (in mice) to homologs of genes already associated to the human disease, strengthening the hypothesis that the gene is indeed involved in the disease. Other enhancers are connected to genes not previously associated with the disease, pointing to their possible pathogenetic involvement. Our observations provide a resource for further exploration of neural disease, in parallel with the now widespread genome-wide identification of DNA variants in patients with neural disease.

Coexpression networks identify brain region–specific enhancer RNAs in the human brain

Enhancer RNAs predict enhancer–gene regulatory links and are critical for enhancer function in neuronal systems

Enhancers Active in Dopamine Neurons Are a Primary Link Between Genetic Variation and Neuropsychiatric Disease.

An Emerging Role for Enhancer RNAs in Brain Disorders

Insights into Enhancer RNAs: Biogenesis and Emerging Role in Brain Diseases

Bridging between Mouse and Human Enhancer-Promoter Long-Range Interactions in Neural Stem Cells, to Understand Enhancer Function in Neurodevelopmental Disease

Genetic regulation of lncRNA expression in the whole human brain

Transcriptome-Wide Profiling of Nascent RNA in Neurons with Enriched H3K27ac Signal Elevates eRNA Identification Efficiency

Validation of Enhancer Regions in Primary Human Neural Progenitor Cells using Capture STARR-seq

Enhancer RNA (eRNA) in Human Diseases

Network Analysis of Enhancer-Promoter Interactions Highlights Cell-Type-Specific Mechanisms of Transcriptional Regulation Variation

Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers

Co-expression Networks Uncover Regulation of Splicing and Transcription Markers of Disease.

eRNA co-expression network uncovers TF dependency and convergent cooperativity

cis-Regulatory Chromatin Contacts in Neural Cells Reveal Contributions of Genetic Variants to Complex Neurological Disorders

Long-Range Enhancer Networks Gradually Emerge as Key Regulators During Human Cortical Neurogenesis

Genome‐wide Association Study and Identification of Chromosomal Enhancer Maps in Multiple Brain Regions Related to Autism Spectrum Disorder

Characterization of enhancer activity in early human neurodevelopment using Massively Parallel Reporter Assay (MPRA) and forebrain organoids

Prioritizing Genes Associated with Brain Disorders by Leveraging Enhancer-Promoter Interactions in Diverse Neural Cells and Tissues

BRAIN-MAGNET: A novel functional genomics atlas coupled with convolutional neural networks facilitates clinical interpretation of disease relevant variants in non-coding regulatory elements

Identifying a ubiquitous gene expression variation pattern in the human brain